Celsion’s Novel TheraSilence Technology Yields Positive Outcomes in Treating PH
Lung Disease News,
This week, New Jersey based biopharmaceutical company Celsion, whose mission is the development of innovative, targeted…
Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension
Overview of attention for article published in Journal of Controlled Release, May 2015
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (83rd percentile)
-
High Attention Score compared to outputs of the same age and source (88th percentile)
Readers on
- mendeley
- 94 Mendeley